Table 4.

Previous Reports of Patients With HJV Mutations Presenting Above the Age of 30 Years.

Year	Age	Sex	Diabetes	Cardiac	TS, %	Ferritin, ng/mL	HFE	HJV	Ref
2005	48	M	Yes	AF	95	6115	No	D249H	14
	51	M	Yes	CCF	96	2280	No	Q312X
	51	F	Yes	?	96	4278	No	Q312X
2009	32	M	No	?	100	3756	No	L194P	15
2010	31	F	?	No	85	3542	No	G320V	16
2010	58	F	?	?	60	443	H63Da	A310Ga	17
	46	F	?	?	95	2794	No	c.-36G > C
2013	39	F	?	CCF	100	116,070	No	G320V	18
2014	37	M	Yes	No	60	>2000	No	Q6Ha C321Xa	19
	47	M	Yes	?	40	>2000	No
2018	45	M	Yes	No	94	3136	H63Da	G336X	7
	49	F	No	No	100	1700	No	G336X
	38	F	Yes	No	69	9400	No	G336X
	47	M	Yes	Yes	91	12,433	No	G336X
	43	M	Yes	No	79	2800	No	c.-36G > A c.-358G > A
	32	F	Yes	Yes	68	4250	No
2018	68	F	Yes	Yes	99	3987	No	C317S	20
2018	53	M	No	?	86	4220		R41Pa R176Ca	21
	31	M	No	?	91	3700		G320V
	31	M	No	?	100	2300		L101Pa H180Ra
	60	F	Yes	?	86	4800		L101Pa A384Va
	32	M	No	?	90	4959		R288W

AF, atrial fibrillation; CCF, congestive cardiac failure; HFE, homeostatic iron regulator; HJV, hemojuvelin; TS, transferrin saturation; ?, Not specified.

^aHeterozygous.